Thomas J. Herzfeld Advisors, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$115,800
-4.4%
1,2000.0%0.04%
-6.2%
Q2 2023$121,092
+9.7%
1,2000.0%0.05%
+6.7%
Q1 2023$110,400
+1.4%
1,2000.0%0.04%0.0%
Q4 2022$108,864
+14.6%
1,200
-3.5%
0.04%
+9.8%
Q3 2022$95,000
-9.5%
1,2440.0%0.04%
-4.7%
Q2 2022$105,000
-3.7%
1,2440.0%0.04%
+4.9%
Q1 2022$109,0000.0%1,2440.0%0.04%
+2.5%
Q4 2021$109,000
+6.9%
1,2440.0%0.04%
-11.1%
Q3 2021$102,000
-10.5%
1,2440.0%0.04%
-6.2%
Q2 2021$114,000
+8.6%
1,244
+1.0%
0.05%0.0%
Q1 2021$105,000
-9.5%
1,2320.0%0.05%
-11.1%
Q4 2020$116,000
+20.8%
1,2320.0%0.05%
-15.6%
Q3 2020$96,000
-5.0%
1,2320.0%0.06%
+28.0%
Q2 2020$101,000
-10.6%
1,232
-9.9%
0.05%
-16.7%
Q1 2020$113,000
-13.1%
1,3680.0%0.06%
+30.4%
Q4 2019$130,000
+9.2%
1,3680.0%0.05%
+4.5%
Q3 2019$119,000
-3.3%
1,368
+1.3%
0.04%
-6.4%
Q2 2019$123,000
+136.5%
1,350
+118.1%
0.05%
+147.4%
Q1 2019$52,000
+4.0%
619
+5.6%
0.02%
-5.0%
Q4 2018$50,000
+16.3%
586
+17.2%
0.02%
+33.3%
Q3 2018$43,000
+13.2%
5000.0%0.02%
+7.1%
Q2 2018$38,000
-5.0%
5000.0%0.01%
-6.7%
Q1 2018$40,000
-4.8%
5000.0%0.02%
-6.2%
Q4 2017$42,000
-2.3%
5000.0%0.02%
-15.8%
Q3 2017$43,0005000.02%
Other shareholders
NOVARTIS A G shareholders Q3 2019
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders